http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104684904-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2601-08 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-381 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D333-38 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-381 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-38 |
| filingDate | 2013-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2017-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2017-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104684904-B |
| titleOfInvention | Mitigate central cornea by using the hydrophilic ester prodrug of β chlorine pentamethylene to thicken |
| abstract | The present invention is provided to treat the composition and method of glaucoma.Specifically, the hydrophilic ester prodrug of offer formula (I) of the present invention and formula (III) and for mitigating the compound that central cornea is thickened, wherein L1 L3, R1 and R2 is as defined in claim 1 and n and R2D is as defined in claim 37. |
| priorityDate | 2012-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 174.